Results 11 to 20 of about 19,175 (268)

Rhodotorula mucilaginosa Fungemia, a Rare Opportunistic Infection without Central Venous Catheter Implantation, Successfully Treated by Liposomal Amphotericin B

Case Reports in Infectious Diseases, 2022
Background. Fungemia due to Rhodotorula mucilaginosa is rare and highly resistance to antifungal therapy. Since most cases of R. mucilaginosa fungemia are attributed to medical devices, limited information is currently available on infection without ...
Ryuichi Hirano, Tatsuro Mitsuhashi, Katsuyoshi Osanai   +2 more
doaj   +2 more sources

Fungemia in Hospitalized Adult Patients with Hematological Malignancies: Epidemiology and Risk Factors

Journal of Fungi, 2023
Fungemia in hematologic malignancies (HM) has high mortality. This is a retrospective cohort of adult patients with HM and fungemia between 2012 and 2019 in institutions of Bogotá, Colombia.
Luz Alejandra Vargas-Espíndola, Sonia I. Cuervo-Maldonado, José L. Enciso-Olivera, Julio C. Gómez-Rincón, Leydy Jiménez-Cetina, Ricardo Sánchez-Pedraza, Katherine García-Guzmán, María José López-Mora, Carlos A. Álvarez-Moreno, Jorge Alberto Cortés, Javier R. Garzón-Herazo, Samuel Martínez-Vernaza, Claudia R. Sierra-Parada, Bryan A. Murillo-Sarmiento   +13 more
doaj   +2 more sources

Fungemia and Other Fungal Infections Associated with Use of Saccharomyces boulardii Probiotic Supplements

Emerging Infectious Diseases, 2021
Because of widespread use of probiotics, their safety must be guaranteed. We assessed use of Saccharomyces boulardii probiotic yeast from medical records for patients who had Saccharomyces fungemia or other clinical Saccharomyces culture findings.
Juha Rannikko, Ville Holmberg, Matti Karppelin, Pertti Arvola, Reetta Huttunen, Eero Mattila, Niina Kerttula, Teija Puhto, Ülle Tamm, Irma Koivula, Risto Vuento, Jaana Syrjänen, Ulla Hohenthal   +12 more
doaj   +2 more sources

Analysis of Candida auris fungemia at a single facility in Kenya [PDF]

International Journal of Infectious Diseases, 2019
Rodney D. Adam, Gunturu Revathi, Nancy Okinda, M Fontaine, Jasmit Shah, Elizabeth Kagotho, Mariana Castanheira, Michael A. Pfaller, Daniel Maina   +8 more
openalex   +2 more sources

Characteristics, costs, and outcomes associated with central-line–associated bloodstream infection and hospital-onset bacteremia and fungemia in US hospitals

Infection control and hospital epidemiology, 2023
Objectives: To compare characteristics and outcomes associated with central-line–associated bloodstream infections (CLABSIs) and electronic health record–determined hospital-onset bacteremia and fungemia (HOB) cases in hospitalized US adults. Methods: We
Kalvin C. Yu, M. Jung, Chin-En Ai
semanticscholar   +1 more source

Hospital-onset bacteremia and fungemia: examining healthcare-associated infections prevention through a wider lens

Antimicrobial Stewardship and Healthcare Epidemiology, 2023
A hospital-onset bacteremia and fungemia (HOB) metric will expand hospital surveillance of bloodstream infections beyond current state and provide an opportunity to re-evaluate infection prevention strategies.
Gregory M. Schrank, G. Snyder, S. Leekha
semanticscholar   +1 more source

Impact of the COVID-19 Pandemic on the Clinical Profile of Candidemia and the Incidence of Fungemia Due to Fluconazole-Resistant Candida parapsilosis

Journal of Fungi, 2022
Severely ill COVID-19 patients are at high risk of nosocomial infections. The aim of the study was to describe the characteristics of candidemia during the pre-pandemic period (January 2019–February 2020) compared to the pandemic period (March 2020 ...
A. Ramos-Martínez, I. Pintos-Pascual, J. Guinea, A. Gutiérrez-Villanueva, Edith Gutiérrez-Abreu, Judith Díaz-García, Á. Asensio, R. Iranzo, I. Sánchez‐Romero, María Muñoz-Algarra, V. Moreno-Torres, J. Calderón-Parra, E. Múñez, A. Fernández‐Cruz   +13 more
semanticscholar   +1 more source

Hospital-onset bacteremia and fungemia: An evaluation of predictors and feasibility of benchmarking comparing two risk-adjusted models among 267 hospitals

Infection control and hospital epidemiology, 2022
Objectives: To evaluate the prevalence of hospital-onset bacteremia and fungemia (HOB), identify hospital-level predictors, and to evaluate the feasibility of an HOB metric.
Kalvin C. Yu, Gang Ye, J. Edwards, Vikas Gupta, A. Benin, Chin-En Ai, Raymund B. Dantes   +6 more
semanticscholar   +1 more source

Factors Associated with Breakthrough Fungemia Caused by Candida, Trichosporon, or Fusarium Species in Patients with Hematological Disorders

Antimicrobial Agents and Chemotherapy, 2022
Limited data are available on breakthrough fungemia, defined as fungemia that develops on administration of antifungal agents, in patients with hematological disorders.
M. Kimura, Y. Asano‐Mori, T. Sakoh, M. Abe, Keigo Ueno, Yasutaka Hoshino, Shigeki Nakamura, T. Umeyama, S. Yamagoe, Y. Miyazaki, Masaru Baba, Chikako Okada, Sho Ogura, Takashi Mitsuki, K. Yamaguchi, M. Yuasa, D. Kaji, K. Kageyama, A. Nishida, Y. Taya, K. Ishiwata, S. Takagi, Hisashi Yamamoto, G. Yamamoto, N. Uchida, A. Wake, S. Taniguchi, H. Araoka   +27 more
semanticscholar   +1 more source

Fatal Lodderomyces elongisporus Fungemia in a Premature, Extremely Low-Birth-Weight Neonate

Journal of Fungi, 2022
Many rare yeasts are emerging as pathogens, causing invasive infections in susceptible hosts that are associated with poor clinical outcome. Here, we describe the first and fatal case of Lodderomyces elongisporus fungemia in a premature, extremely low ...
M. Asadzadeh, N. Al-sweih, Suhail Ahmad, S. Khan, W. Alfouzan, L. Joseph   +5 more
semanticscholar   +1 more source